[HTML][HTML] A four month randomized controlled trial on the efficacy of once-daily fenofibrate monotherapy in persons with spinal cord injury
MF La Fountaine, CM Cirnigliaro, JC Hobson… - Scientific Reports, 2019 - nature.com
… to treat dyslipidemias in the general population 6,7 . … lipoprotein profile, extended-release
niacin (nicotinic acid) was … (ie, paraplegia: ≥135 mg/dl; tetraplegia ≥115 mg/dl) 30 that are …
niacin (nicotinic acid) was … (ie, paraplegia: ≥135 mg/dl; tetraplegia ≥115 mg/dl) 30 that are …
A provider's guide to vascular disease, dyslipidemia, and glycemic dysregulation in chronic spinal cord injury
M Stillman, S Babapoor-Farrokhran… - Topics in spinal …, 2020 - meridian.allenpress.com
… et al demonstrated that extended-release niacin is a safe and … glucose tolerance (IGT) on
oral glucose tolerance tests (OGTT)… been no prospective clinical trials demonstrating reductions …
oral glucose tolerance tests (OGTT)… been no prospective clinical trials demonstrating reductions …
[PDF][PDF] Cardiometabolic disease and dysfunction following spinal cord injury: origins and guideline-based countermeasures
MS Nash, DR Gater Jr - Physical medicine and rehabilitation clinics of North …, 2020 - Elsevier
… Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
risks in persons with chronic tetraplegia: a randomized multicenter controlled trial. Arch …
Identification and management of cardiometabolic risk after spinal cord injury
… people with tetraplegia compared with paraplegia, especially … monotherapy, which may be
more impactful on persons with … Niacin tolerably improves the dyslipidemic risk profile in SCI. …
more impactful on persons with … Niacin tolerably improves the dyslipidemic risk profile in SCI. …
[HTML][HTML] Identification and management of cardiometabolic risk after spinal cord injury: clinical practice guideline for health care providers
MS Nash, SL Groah, DR Gater Jr… - Topics in spinal cord …, 2018 - ncbi.nlm.nih.gov
… people with tetraplegia compared with paraplegia, especially … monotherapy, which may be
more impactful on persons with … Niacin tolerably improves the dyslipidemic risk profile in SCI.…
more impactful on persons with … Niacin tolerably improves the dyslipidemic risk profile in SCI.…
[HTML][HTML] Mortality benefit of statin use in traumatic spinal cord injury: a retrospective analysis
MD Stillman, CE Aston, MH Rabadi - Spinal Cord, 2016 - nature.com
… Safety, tolerance, and efficacy of extended-release niacin monotherapy for treating dyslipidemia
risks in persons with chronic tetraplegia: A randomized multicenter controlled trial. Arch …
risks in persons with chronic tetraplegia: A randomized multicenter controlled trial. Arch …
Bioactive role of vitamins as a key modulator of oxidative stress, cellular damage and comorbidities associated with spinal cord injury (SCI)
KA Pedroza-García, G Careaga-Cárdenas… - Nutritional …, 2023 - Taylor & Francis
… Results: Consistent benefits in clinical trials were shown in those who were supplemented
… Moreover, SCI patients with dyslipidemia who were supplemented with niacin monotherapy …
… Moreover, SCI patients with dyslipidemia who were supplemented with niacin monotherapy …
Guideline for the identification and management of cardiometabolic risk after spinal cord injury: a case of unsubstantiated recommendations
MD Stillman, S Williams - Spinal cord series and cases, 2019 - nature.com
… of glycemic dysregulation and dyslipidemia—have been offered … that Niacin therapy improves
the lipid profiles of people with … -controlled trial investigating statin use in people with risk …
the lipid profiles of people with … -controlled trial investigating statin use in people with risk …
Establishing a threshold to predict risk of cardiovascular disease from the serum triglyceride and high-density lipoprotein concentrations in persons with spinal cord …
MF La Fountaine, CM Cirnigliaro, JC Hobson… - Spinal Cord, 2018 - nature.com
… randomized, single-blind, placebo controlled clinical trial with nicotinic acid (eg, Niaspan)
was performed in persons with tetraplegia and found to be effective at increasing HDL-C by ~…
was performed in persons with tetraplegia and found to be effective at increasing HDL-C by ~…
Diagnosis and Management of Cardiovascular Risk in Individuals With Spinal Cord Injury: A Narrative Review
… cardiovascular disease risk factors, including dyslipidemia and … pressure monitoring in
people with both tetraplegia (cervical … Niacin is not recommended for treatment of lipid disorders …
people with both tetraplegia (cervical … Niacin is not recommended for treatment of lipid disorders …